Clinical trial
Hardwins - Squamous Cell Carcinoma Head & Neck (Surgery/RT)
NCT00188318 · University Health Network, Toronto, Other · Completed
Key facts
| NCT number | NCT00188318 |
|---|---|
| Title | Hardwins - Squamous Cell Carcinoma Head & Neck (Surgery/RT) |
| Official title | A Phase II Study of Hyperfractionated Accelerated Radiotherapy Delivered With Integrated Neck Surgery for Node-positive Cases in Squamous Cell Carcinoma of the Head and Neck |
| Lead sponsor | University Health Network, Toronto, Other |
| Collaborators | Princess Margaret Hospital, Canada |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Carcinoma, Squamous Cell |
| Intervention type | Procedure |
| Interventions | hyperfractionated accelerated radiotherapy |
| Enrollment | 169 |
| Start date | Jun 1, 1998 |
| Primary completion | May 1, 2010 |
| Completion | May 1, 2010 |
| First posted | Sep 16, 2005 |
| Last update posted | Feb 9, 2016 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: